synthesi
biolog
evalu
novel
seri
dimer
camphor
deriv
describ
result
compound
studi
antivir
activ
cytoand
genotox
compound
quaternari
nitrogen
atom
separ
aliphat
chain
exhibit
highest
effici
agent
inhibit
reproduct
influenza
viru
cytotox
data
compound
reveal
moder
activ
malign
cell
line
compound
highest
activ
cell
result
show
close
agreement
data
independ
studi
toxic
compound
particular
toxic
compound
strongli
depend
spacer
length
function
natur
compound
exhibit
nativ
biolog
activ
one
effici
approach
synthesi
biolog
activ
substanc
medicin
chemistri
symmetr
nitrogencontain
molecul
bear
least
two
natur
fragment
link
spacer
becom
wide
use
medic
applic
type
natur
fragment
rather
divers
alkaloid
steroid
monoor
diterpen
etc
thu
dimer
trimer
compound
exhibit
strongli
pronounc
antitumor
effect
synthes
base
artemizinin
hybrid
steroid
framework
studi
analogu
juvenil
hormon
strategi
bival
ligand
success
implement
search
acetylcholinesteras
inhibitor
alkaloid
tarcin
galanthamin
use
start
natur
compound
bisderiv
appear
promis
agent
treat
alzheim
diseas
exampl
literatur
dimer
molecul
acquir
properti
complet
differ
precursor
molecul
inde
symmetr
deriv
alkaloid
camphotecin
enhanc
solubl
compound
reduc
toxic
increas
specif
interact
enzym
meanwhil
symmetr
compound
contain
two
quaternari
nitrogen
atom
separ
differ
size
spacer
gener
known
exhibit
high
biolog
activ
agent
wide
use
myorelax
furthermor
mani
test
antimalari
drug
howev
exampl
synthesi
dimer
compound
base
natur
molecul
link
quaternari
nitrogen
atom
via
spacer
publish
exampl
ammonium
deriv
diterpenoid
steviol
isosteviol
exhibit
antimicrobi
properti
dimer
steroid
act
catalyst
henc
synthesi
compound
contain
sever
natur
fragment
link
spacer
group
involv
insert
two
quatern
nitrogen
atom
promis
trend
chemistri
biolog
activ
substanc
present
studi
describ
biolog
activ
novel
class
chemic
compoundsdimer
camphor
deriv
among
type
activ
investig
abil
suppress
reproduct
influenza
viru
sever
exampl
use
similar
cage
structur
antivir
compound
well
known
adamantan
deriv
amantadin
rimantadin
first
antivir
influenza
isoborneol
deriv
also
shown
possess
antivir
activ
influenza
see
front
matter
elsevi
ltd
right
reserv
http
viru
base
amino
deriv
isoborneol
antiinfluenza
drug
deitiforin
licens
former
soviet
union
influenza
treatment
mechan
activ
suppos
similar
rimantadin
sever
attempt
undertaken
optim
molecul
amantadin
overcom
viru
resist
particular
adamantanebas
spiroderiv
test
influenza
viru
demonstr
high
inhibit
activ
regard
activ
spiro
adamantan
appear
compar
amantadin
appear
less
effect
moreov
none
demonstr
activ
influenza
b
viru
thu
suggest
specif
target
activ
absent
influenza
b
virus
although
adamantanebas
cage
structur
compound
call
bananin
deriv
hydroxymethyl
test
influenza
viru
compound
shown
inhibit
sar
coronavirusspecif
helicas
scv
cellfre
system
effect
inhibitor
atpas
activ
scv
helicas
ic
valu
rang
lm
anoth
group
antiinfluenza
compound
repres
cage
structur
close
camphor
scaffoldpinanamin
previous
shown
appear
potent
amantadin
inhibit
amantadinesuscept
influenza
viru
moreov
although
rel
high
concentr
pinanamin
deriv
abl
inhibit
amantadineresist
mutant
bear
mutat
fact
suggest
princip
possibl
overcom
resist
influenza
virus
adamantan
deriv
use
cage
scaffoldbas
compound
target
adamantan
deriv
virusspecif
proton
channel
initi
compound
suppos
interact
intern
channel
protein
gener
proton
form
compound
consid
block
tetramer
ion
channel
pore
form
transmembran
domain
henc
proton
transport
function
amino
acid
substitut
confer
rimantadineresist
phenotyp
local
posit
nmr
solut
reveal
anoth
adamantanebind
site
around
amino
acid
posit
studi
suggest
rimantadin
bound
outsid
protein
helic
face
lipid
bilay
residu
particip
hydrogen
bond
interact
rimantadin
postul
highaffin
bind
site
correspond
ion
channel
pore
wherea
secondari
lowaffin
bind
site
could
attribut
lipid
face
pore
two
studi
propos
differ
site
differ
model
interact
adamantan
drug
first
anion
channel
porebind
model
second
lipidfac
bind
model
later
case
drug
shown
inhibit
channel
outsid
alloster
mechan
stabil
close
state
common
featur
inhibitor
known
far
presenc
primari
amin
group
link
hydrophob
scaffold
exist
extern
bind
site
adamantan
deriv
broaden
set
modif
compound
suppress
ion
channel
activ
narrow
pore
channel
restrict
size
charg
compound
must
fit
pore
order
inhibit
effect
hand
develop
compound
interact
amino
acid
andor
lipid
bilay
outsid
channel
one
may
use
much
wider
set
side
substitu
case
factor
becom
import
bind
particular
abil
compound
interact
simultan
lipid
membran
bilay
extern
amino
acid
transmembran
region
camphor
abund
monoterpenoid
bicycl
framework
structur
select
start
compound
imin
synthes
via
interact
compound
n
condit
azeotrop
remov
water
toluen
presenc
bf
yield
scheme
order
synthes
symmetr
dimer
molecul
dihalogenid
differ
size
structur
type
use
spacer
interact
compound
boil
acetonitril
gave
rise
target
compound
result
salt
contain
two
quaternari
nitrogen
atom
isol
use
silica
gel
column
chromatographi
order
studi
effect
structur
compound
biolog
activ
spacerfre
analoguescompound
contain
singl
quaternari
nitrogen
atomhav
synthes
noesi
data
dft
quantum
chemic
calcul
compound
gave
ground
propos
structur
e
configur
imino
group
target
compound
thu
spectrum
imin
contain
noe
cross
peak
proton
signal
carbon
atom
c
c
calcul
distanc
nearest
proton
specifi
group
e
z
configur
cross
peak
also
observ
well
enabl
unambigu
assign
signal
fig
follow
calcul
data
e
configur
kcalmol
energet
profit
z
configur
let
us
mention
similar
camphor
imin
previous
also
classifi
e
isom
insuffici
solubl
compound
cdcl
nmr
spectra
record
meohd
substitut
proton
exo
posit
bornan
framework
deuterium
atom
observ
deuter
degre
vari
sampl
sampl
presum
attribut
differ
solvent
exposur
time
slightli
vari
acid
medium
sampl
substitut
vinyl
posit
imin
meohd
solut
observ
rather
frequent
occur
due
presenc
tautomer
equilibrium
enamin
form
broaden
signal
certain
carbon
atom
signal
carbon
atom
c
imino
group
particular
observ
c
nmr
spectra
compound
b
equimolar
amount
triethylamin
ad
sampl
dissolv
meohd
order
freez
chemic
exchang
narrow
nmr
spectral
line
obtain
compound
b
studi
potenti
antivir
agent
natur
compound
consid
prospect
sourc
develop
novel
antivir
usa
half
novel
drug
approv
clinic
use
past
decad
natur
compound
chemic
modifi
deriv
antivir
influenza
drug
resist
viru
report
bestknown
etiotrop
drug
influenza
treatment
adamantan
deriv
amantadin
symmetrel
rimantadin
hydrochlorid
compound
block
viral
ion
channel
thu
prevent
proton
flow
virion
cleavag
hemagglutinin
fusion
membran
viral
envelop
lysosom
vacuol
studi
activ
compound
b
influenza
viru
reveal
high
efficaci
inhibitor
viru
reproduct
valu
antivir
activ
select
compound
exceed
refer
compound
amantadin
rimantadin
seen
result
obtain
activ
substanc
symmetr
deriv
aliphat
spacer
note
toxic
compound
strongli
depend
spacer
length
regard
compound
c
c
h
c
h
linker
respect
possess
lowest
toxic
ctd
lm
correspondingli
compound
appear
effect
low
ec
high
ctd
si
latter
exceed
si
refer
compound
tabl
studi
use
adamantan
deriv
amantadin
rimantadin
well
isoborneol
deriv
deitiforin
compound
similar
synthes
cours
studi
base
cage
structur
adamantan
amantadin
rimantadin
isoborneol
deitiforin
compound
b
indic
previous
influenza
viru
contain
protonselect
ion
channel
target
adamantan
famili
drug
inhibitor
despit
structur
similar
camphor
deriv
rimantadin
deitiforin
appear
activ
pandem
influenza
strain
resist
adamantan
deriv
suggest
target
site
compound
includ
amino
acid
differ
interact
rimantadin
inde
molecular
model
interact
dimeri
camphor
deriv
reveal
preferenti
bind
two
adjac
chain
tetram
fig
region
amino
acid
model
allow
specul
linker
specif
length
confer
symmetr
dimer
deriv
camphor
higher
activ
compar
monom
tetram
consist
four
peptid
four
site
molecul
abl
interact
camphor
deriv
present
figur
combin
two
camphor
moieti
one
molecul
might
increas
probabl
bind
increas
strength
bind
especi
two
moieti
link
linker
appropri
length
allow
reach
two
bind
site
word
two
camphor
moieti
link
bind
one
moieti
target
increas
probabl
bind
second
moieti
neighbor
bind
site
compar
two
independ
molecul
suggest
undoubtedli
subject
studi
global
practic
studi
toxic
mutagen
effect
variou
compound
organ
mainli
base
detect
immun
physiolog
disord
organ
manifest
new
phenotyp
featur
number
lower
organ
howev
kind
research
timeconsum
requir
expens
equip
use
necessarili
enabl
unambigu
interpret
result
rapid
method
detect
organ
contamin
heavi
metal
environment
object
well
determin
total
toxic
genotox
analyz
compound
propos
past
year
recombin
wholecel
bacteri
biosensor
base
escherichia
coli
microorgan
speci
use
test
cultur
design
wholecel
biosensor
report
protein
gene
link
regulatori
element
gene
character
dosedepend
respons
toxic
genotox
chemic
compound
extern
factor
exposur
uv
light
radiat
temperatur
chang
physiolog
signal
either
green
fluoresc
protein
gfp
isol
jellyfish
aequorea
victoria
luciferas
vibrio
fischeri
use
report
protein
two
previous
design
wholecel
biosensor
test
kit
base
e
coli
cell
contain
pracgfp
plasmid
use
work
evalu
possibl
toxic
mutagen
properti
compound
studi
gfp
use
report
protein
test
kit
express
gfp
protein
gene
cell
biosensor
carri
pracgfp
plasmid
control
regulatori
region
reca
gene
proteu
mirabili
link
demonstr
e
coli
strain
use
indic
strain
ensur
detect
mutagen
physic
chemic
natur
design
wholecel
biosensor
presum
also
use
studi
genotox
effect
variou
compound
novel
drug
dietari
supplement
foodstuff
fluoresc
valu
gfp
synthes
cell
two
type
wholecel
biosensor
e
colipracgfp
e
intend
assess
possibl
mutagen
toxic
effect
analyz
compound
list
column
control
water
neg
control
nalidix
acid
concentr
lgl
posit
control
respect
ad
e
colipracgfp
cell
cultur
instead
analyz
compound
control
water
introduc
e
coli
cell
cultur
instead
analyz
compound
h
iptg
also
ad
final
concentr
mm
anoth
variant
wholecel
biosensor
base
e
coli
strain
carri
plasmid
ensur
iptg
induc
express
gfp
gene
contain
regul
bacteriophag
promot
toxic
effect
compound
studi
biosensor
cell
accompani
inhibit
macromolecular
synthesi
reaction
includ
protein
synthesi
reaction
particular
iptginduc
synthesi
gfp
total
toxic
effect
compound
studi
cell
estim
decreas
induc
synthesi
gfp
tabl
list
result
determin
possibl
mutagen
toxic
effect
compound
cell
e
coli
biosensor
strain
carri
pracgfp
plasmid
follow
data
list
tabl
compound
neither
toxic
mutagen
effect
bacteri
indic
cell
e
ecolipracgfp
moreov
none
analyz
compound
exhibit
genotox
effect
cell
biosensor
strain
e
colipracgfp
howev
compound
turn
highli
toxic
two
type
indic
cell
direct
depend
rise
toxic
symmetr
dimer
molecul
camphor
deriv
studi
increas
length
aliphat
spacer
compound
exhibit
highest
toxic
compound
unquestion
interest
term
put
applic
compon
drug
suppress
malign
tumor
develop
antivir
antibacteri
agent
tabl
cytotox
activ
synthes
compound
determin
measur
concentr
inhibit
tumor
cell
viabil
ctd
ctd
determin
use
convent
mtt
assay
allow
estim
number
surviv
cell
result
demonstr
compound
exhibit
moder
activ
respect
model
cancer
cell
line
within
micromolar
rang
compound
possess
highest
activ
moreov
compar
cytotox
compound
regard
four
cell
line
use
studi
mdck
note
mdck
cell
appear
much
resist
toxic
action
camphor
deriv
may
explain
differ
condit
cultiv
cell
line
ii
select
toxic
compound
studi
lymphoblastoid
cell
compar
one
epitheli
origin
studi
therefor
requir
get
addit
data
evalu
properti
symmetr
camphor
deriv
potenti
cytotox
anticanc
agent
seri
symmetr
compound
two
camphor
fragment
framework
two
imin
group
two
quaternari
nitrogen
atom
separ
spacer
differ
size
synthes
antivir
activ
cytoand
genotox
result
compound
studi
compound
quaternari
nitrogen
atom
separ
c
h
aliphat
chain
exhibit
highest
effici
agent
inhibit
reproduct
influenza
viru
strain
therapeut
index
compound
higher
compar
drug
amantadin
rimantadin
worth
mention
synthes
camphor
imin
stabl
crystallin
compound
undergo
neither
destruct
polymer
long
period
cytotox
data
compound
demonstr
exhibit
moder
anticanc
activ
compound
highest
activ
cell
line
result
show
close
agreement
data
independ
studi
genotox
cytotox
compound
compound
exhibit
highest
toxic
detail
studi
compound
interest
term
put
applic
compon
drug
suppress
malign
tumor
develop
reagent
solvent
purchas
commerci
supplier
use
receiv
dri
solvent
obtain
accord
standard
procedur
optic
rotat
polaar
spectromet
chcl
soln
h
c
nmr
spectra
record
bru
puriti
target
compound
determin
ga
chromatographi
method
target
compound
report
paper
puriti
less
numer
atom
compound
given
assign
signal
nmr
spectra
coincid
name
accord
nomenclatur
compound
see
supplementari
data
specif
rotat
express
deg
ml
g
dm
concentr
express
g
ml
camphor
mmol
n
n
mmol
mix
toluen
catalyt
bf
mol
follow
azeotrop
remov
water
deanstark
h
reaction
mixtur
wash
satur
nacl
solut
organ
layer
separ
aqueou
layer
extract
ch
cl
ml
combin
organ
phase
dri
na
solvent
evapor
residu
separ
vacuum
distil
torr
result
obtain
yield
g
mmol
reaction
mixtur
reflux
h
gave
compound
g
mmol
mp
found
deuteriumsubstitut
second
exoposit
compound
spectra
nmr
signal
deuteriumsubstitut
compound
differ
unsubstitut
mark
asterisk
nmr
h
mhz
cd
reaction
mixtur
reflux
h
gave
compound
g
mmol
mp
found
deuteriumsubstitut
second
exoposit
compound
spectra
nmr
signal
deuteriumsubstitut
compound
differ
unsubstitut
mark
asterisk
nmr
h
mhz
cd
reaction
mixtur
reflux
h
gave
compound
g
mmol
mp
found
deuteriumsubstitut
second
exoposit
compound
spectra
nmr
signal
deuteriumsubstitut
compound
differ
unsubstitut
mark
asterisk
nmr
h
mhz
cd
reaction
mixtur
reflux
h
gave
compound
g
mmol
found
deuteriumsubstitut
second
exoposit
compound
spectra
nmr
signal
deuteriumsubstitut
compound
differ
unsubstitut
mark
asterisk
reaction
mixtur
reflux
h
gave
compound
g
mmol
mp
microtetrazolium
test
mtt
use
studi
cytotox
compound
mossman
briefli
seri
twofold
dilut
compound
lgml
mem
prepar
mdck
cell
incub
h
co
presenc
dissolv
substanc
degre
destruct
cell
monolay
determin
microtetrazolium
test
mtt
cell
wash
twice
salin
solut
bromid
icn
biochem
inc
aurora
ohio
lgml
salin
ad
well
h
incub
well
wash
formazan
residu
dissolv
dmso
ml
per
well
optic
densiti
cell
measur
victor
multifunct
reader
perkin
elmer
finland
wavelength
nm
plot
concentr
compound
compound
concentr
test
three
parallel
cytotox
dose
ctd
compound
ie
compound
concentr
caus
death
cell
cultur
decreas
optic
densiti
twice
compar
control
well
calcul
data
obtain
compound
appropri
concentr
incub
mdck
cell
h
cell
cultur
infect
dilut
viru
plate
incub
h
presenc
co
infect
activ
viru
evalu
hemagglutin
reaction
chicken
erythrocyt
viruscontain
solut
place
well
roundbottom
plate
equal
amount
suspens
chicken
erythrocyt
salin
ad
reaction
evalu
min
incub
room
temperatur
concentr
compound
test
three
parallel
viru
titer
consid
reciproc
decim
logarithm
maximum
dilut
caus
complet
agglutin
erythrocyt
express
logarithm
experiment
infect
dose
log
eid
antivir
activ
compound
estim
decreas
viru
titer
compar
control
effect
concentr
ec
drug
concentr
viru
product
decreas
factor
two
viru
titer
per
log
eid
select
index
ratio
ctd
ec
calcul
data
obtain
assess
genotox
toxic
compound
studi
use
wholecel
biosensor
possibl
mutagen
toxic
effect
terpenoid
cell
e
coli
biosensor
strain
carri
pracgfp
petmgfp
plasmid
determin
accord
follow
scheme
overnight
cultur
e
coli
biosensor
strain
reseed
vial
fresh
lb
cultur
grown
shaker
optic
densiti
reach
differ
amount
analyz
terpenoid
introduc
vial
cultur
grown
addit
h
next
vial
contain
biosensor
strain
carri
pracgfp
plasmid
incub
h
ensur
matur
gfp
chromophor
final
stage
optic
densiti
cell
suspens
type
biosensor
determin
vial
nm
fluoresc
spectrum
record
spectrofluorophotomet
shimadzu
japan
rang
nm
excit
wavelength
k
exit
nm
decreas
averag
fluoresc
intens
compar
control
toxic
criterion
analyz
compound
decreas
indic
compound
toxic
extrem
toxic
respect
biosensor
strain
cell
carri
petmgfp
plasmid
treat
compound
studi
mm
iptginduc
gfp
gene
express
stimul
use
control
fluoresc
induc
control
cell
suppos
increas
least
compar
uninduc
biosensor
cell
human
cancer
cell
cell
tcellular
human
leucosi
human
monocyt
use
studi
cell
cultur
medium
contain
embryon
calf
serum
lglutamin
mmoll
gentamicin
lgml
lincomycin
mgml
co
incub
compound
dissolv
dmso
ad
cellular
cultur
requir
concentr
cell
place
microlit
plate
cultiv
co
air
h
three
well
use
concentr
cell
incub
without
compound
use
control
cell
viabil
assess
mtt
bromid
convers
assay
mtt
ad
well
four
hour
later
dmso
ad
mix
min
final
optic
densiti
valu
monitor
nm
molecular
dock
model
interact
compound
investig
influenza
viru
protein
protein
databas
code
done
hex
onlin
server
http
hexserverloriafr
